Tubo-Ovarian Cancer Histotypes in Patients With Germline BRCA1 or BRCA2 Mutations

被引：0
|
作者：
Gilks, C. Blake
McCluggage, W. Glenn
Brady, Aidan
Singh, Naveena
Huntsman, David
Provencher, Diane
Mes-Masson, Anne-Marie
Rahimi, Kurosh
机构：
[1] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[2] Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland
[3] Barts Hlth NHS Trust, London, England
[4] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[5] Univ Montreal, Montreal, PQ, Canada
[6] Vancouver Gen Hosp, Vancouver, BC, Canada
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1144
引用
收藏
页码：286A / 286A
页数：1
相关论文
共 50 条
  • [31] High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients
    Al-Joharah Alhuqail
    Areej Alzahrani
    Hannah Almubarak
    Sarah Al-Qadheeb
    Lamyaa Alghofaili
    Nisreen Almoghrabi
    Hamed Alhussaini
    Ben Ho Park
    Dilek Colak
    Bedri Karakas
    Breast Cancer Research and Treatment, 2018, 168 : 695 - 702
  • [32] High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients
    Alhuqail, Al-Joharah
    Alzahrani, Areej
    Almubarak, Hannah
    Al-Qadheeb, Sarah
    Alghofaili, Lamyaa
    Almoghrabi, Nisreen
    Alhussaini, Hamed
    Park, Ben Ho
    Colak, Dilek
    Karakas, Bedri
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (03) : 695 - 702
  • [33] A prospective study about BRCA1/BRCA2 germline mutations in hereditary breast/ovarian cancer patients
    Ben Kridis, W.
    Ben Ayed-Guerfali, D.
    Ammous-Boukhris, N.
    Ayedi, W.
    Charfi, S.
    Boudawara, T.
    Daoud, J.
    Khanfir, A.
    Mokdad-Gargouri, R.
    ANNALS OF ONCOLOGY, 2020, 31 : S1223 - S1223
  • [34] Low BRCA1 and BRCA2 Germline Mutation Rates in a French-Canadian Population with a Diagnosis of Epithelial Tubo-Ovarian Carcinoma
    Bernard, Juliette
    Mehros, Wala
    Gregoire, Jean
    Douville, Pierre
    Renaud, Marie-Claude
    Sebastianelli, Alexandra
    Langlais, Eve-Lyne
    Plante, Marie
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2022, 44 (10) : 1047 - 1053
  • [35] A family with three germline mutations in BRCA1 and BRCA2
    Liede, A
    Metcalfe, K
    Offit, K
    Brown, K
    Miller, S
    Narod, SA
    Moslehi, R
    CLINICAL GENETICS, 1998, 54 (03) : 215 - 218
  • [36] Rucaparib for recurrent ovarian cancer with BRCA1 and BRCA2 mutations
    Ganguly, Shuvadeep
    Gogia, Ajay
    LANCET ONCOLOGY, 2022, 23 (07): : E314 - E314
  • [37] Unwrapping the Implications of BRCA1 and BRCA2 Mutations in Ovarian Cancer
    Hyman, David M.
    Spriggs, David R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04): : 408 - 410
  • [38] Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer
    Ramus, Susan J.
    Harrington, Patricia A.
    Pye, Carole
    DiCioccio, Richard A.
    Cox, Mark J.
    Garlinghouse-Jones, Kim
    Oakley-Girvan, Ingrid
    Jacobs, Ian J.
    Hardy, Richard M.
    Whittemore, Alice S.
    Ponder, Bruce A. J.
    Piver, M. Steven
    Pharoah, Paul D. P.
    Gayther, Simon A.
    HUMAN MUTATION, 2007, 28 (12) : 1207 - 1215
  • [39] An immunohistochemical comparison of ovarian cancers tested for germline BRCA1/BRCA2 mutations
    Djordjevic, B
    Tone, A
    Begley, H
    Murphy, J
    Rosen, B
    McLaughlin, J
    Narod, S
    Shaw, PA
    LABORATORY INVESTIGATION, 2006, 86 : 176A - 176A
  • [40] An immunohistochemical comparison of ovarian cancers tested for germline BRCA1/BRCA2 mutations
    Djordjevic, B
    Tone, A
    Begley, H
    Murphy, J
    Rosen, B
    McLaughlin, J
    Narod, S
    Shaw, PA
    MODERN PATHOLOGY, 2006, 19 : 176A - 176A
12345